Boning Liu
Tianjin Key Laboratory Of Lung Cancer Metastasis And Tumor Microenvironment
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Galectin-9-driven immune evasion constrains radiotherapy-induced systemic antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: March 02, 2026
Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion.
Journal: Journal for immunotherapy of cancer
Published: June 17, 2025
Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity.
Journal: International journal of biological sciences
Published: October 13, 2022
PD-L1 deficiency sensitizes tumor cells to DNA-PK inhibition and enhances cGAS-STING activation.
Journal: American journal of cancer research
Published: February 24, 2022
Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death.
Journal: The Journal of biological chemistry
Published: July 21, 2021
MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITGβ8- JAK2/STAT3 axis.
Journal: Biochemical and biophysical research communications
Published: April 19, 2018
MiR-26a enhances invasive capacity by suppressing GSK3β in human lung cancer cells.
Journal: Experimental cell research
Published: December 08, 2016
Activating transcription factor 3 promotes malignance of lung cancer cells in vitro.
Journal: Thoracic cancer
Published: November 17, 2016
Advances in the research of glycolysis and lung cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: April 19, 2012
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.
Journal: Biochimica et biophysica acta
Published: March 08, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026